Immunogenicity and protective efficacy of prime-boost immunization in mice vaccinated with live and inactivated influenza A (H5N1) vaccines
Avian influenza A (H1N1) in humans is characterized by severe clinical manifestation and high mortality. The main drawback of current human H5N1 vaccines is related to low immunogenicity. Prime-boost vaccination is considered as an effective approach to enhance vaccine immunogenicity. The aim of thi...
Guardado en:
Autores principales: | I. Losev, G. Petukhova, I. Isakova-Sivak, L. Rudenko |
---|---|
Formato: | article |
Lenguaje: | RU |
Publicado: |
Sankt-Peterburg : NIIÈM imeni Pastera
2019
|
Materias: | |
Acceso en línea: | https://doaj.org/article/37f3fc5a738741eea67975ee79e4b01b |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Generation of DelNS1 Influenza Viruses: a Strategy for Optimizing Live Attenuated Influenza Vaccines
por: Pui Wang, et al.
Publicado: (2019) -
Factors Associated with Attitudes towards Seasonal Influenza Vaccination in Poland: A Nationwide Cross-Sectional Survey in 2020
por: Piotr Samel-Kowalik, et al.
Publicado: (2021) -
Heterosubtypic Protection Induced by a Live Attenuated Influenza Virus Vaccine Expressing Galactose-α-1,3-Galactose Epitopes in Infected Cells
por: Li-Meng Yan, et al.
Publicado: (2020) -
Nasal spray live attenuated influenza vaccine: the first experience in Italy in children and adolescents during the 2020–21 season
por: Chiara Gasparini, et al.
Publicado: (2021) -
INDUCTION OF LONG-TERM T AND B CELL MEMORY IMMUNITY TO INFLUENZA A VIRUS (H5N1) IN PERSONS VACCINATED WITH LIVE INFLUENZA A VACCINE (H5N2)
por: I. V. Losev, et al.
Publicado: (2017)